These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4816)

  • 41. 6-Hydroxydopamine and avoidance: Possible role of response suppression.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):873-8. PubMed ID: 1208629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat.
    Hoeldtke R; Rogawski M; Wurtman RJ
    Br J Pharmacol; 1974 Feb; 50(2):265-70. PubMed ID: 4425765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium-induced polydipsia: dependence on nigrostriatal dopamine pathway and relationship to changes in the renin-angiotensin system.
    Mailman RB
    Psychopharmacology (Berl); 1983; 80(2):143-9. PubMed ID: 6410443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of saline consumption in the prevention of deoxycorticosterone hypertension in rats by central 6-hydroxydopamine.
    Lewis PJ; Dargie HJ; Dollery CT
    Clin Sci Mol Med; 1975 Apr; 48(4):327-30. PubMed ID: 1126124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of thyrotropin-releasing hormone on locomotor activity, operant performance and ingestive behavior.
    Vogel RA; Cooper BR; Barlow TS; Prange AJ; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1979 Feb; 208(2):161-8. PubMed ID: 105126
    [No Abstract]   [Full Text] [Related]  

  • 46. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of 6-hydroxydopamine and amphetamine on rat mothering behavior and offspring development.
    Piccirillo M; Alpert JE; Cohen DJ; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):391-5. PubMed ID: 7422694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of central catecholamines in the control of blood pressure and drinking behavior.
    Gordon FJ; Brody MJ; Fink GD; Buggy J; Johnson AK
    Brain Res; 1979 Dec; 178(1):161-73. PubMed ID: 497858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A10 lesion and passive avoidance latency: correlation with limbic tyrosine-hydroxylase-activity.
    Raab A; Kojer G
    Pharmacol Biochem Behav; 1982 Jul; 17(1):77-83. PubMed ID: 6126891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of brain noradrenaline and the pituitary-adrenal axis in learning and extinction.
    Mason ST; Roberts DC; Fibiger HC
    Pharmacol Biochem Behav; 1979 Jan; 10(1):11-6. PubMed ID: 441087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of extended training on rats depleted of central and/or peripheral catecholamines.
    Oei TP; King MG
    Pharmacol Biochem Behav; 1978 Aug; 9(2):243-7. PubMed ID: 714973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Action of intrahypothalamic 6-hydroxydopamine on motivated responding for food and water in the rat.
    Martin GE; Myers RD
    Pharmacol Biochem Behav; 1974 May; 2(3):393-9. PubMed ID: 4837909
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
    Shabanov PD; Bul'on VV; Lénárd L
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alcohol drinking in the rat after destruction of serotonergic and catecholaminergic neurons in the brain.
    Myers RD; Melchior CL
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):363-78. PubMed ID: 1162179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion.
    Zigmond MJ; Stricker EM
    Experientia; 1980 Apr; 36(4):436-8. PubMed ID: 7379917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased disrupting effects of haloperidol on a conditioned avoidance response after 6-hydroxydopamine treatment.
    Monti JM; Ruiz M
    Pharmacol Biochem Behav; 1975; 3(5):943-5. PubMed ID: 1208639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of 6-hydroxydopamine on body weight: feeding deficits or sensory-motor impairments?
    Pelham RW; Lippa AS; Sano MC
    Commun Psychopharmacol; 1977; 1(6):553-63. PubMed ID: 608325
    [No Abstract]   [Full Text] [Related]  

  • 60. Food intake and biogenic amine concentrations in brain regions of chicks following intracerebroventricular injection of six-hydroxydopamine.
    Kuenzel WJ; Snapir N; Rexroad CE
    Pharmacol Biochem Behav; 1987 Jun; 27(2):257-63. PubMed ID: 3114769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.